Preventive effects of Eicosapentaenoic acid (EPA) on stroke recurrence and a symptom state in chronic stroke patients with dyslipidemia.
Not Applicable
Recruiting
- Conditions
- Chronic stroke patients with dyslipidemia
- Registration Number
- JPRN-UMIN000006416
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Following patients will be excluded from this study 1.SBP>=180mmHg or DBP>=110 2.Patirnts who are bleeding (Hemophilia, intracranial bleeding, Gastrointestinal bleeding, Urinary tract bleeding, Hemophysis, Vitreous hemorrhage) 3.Patients with known bleeding disorders or a predisposing condition 4.Severe liver or renal dysfunction 5.Malignancy 6.Scheduling the operation 7.Past history of severe adverse effect by Aspirin or Eicosapentaenoic Acid ethyl ester 8.Patients who are inadequate by physician's decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method